Innovative Monitoring Tech Vixiar Medical’s flagship product, Indicor™, offers a non-invasive, portable solution for monitoring cardiac filling pressures in congestive heart failure patients, providing a cost-effective alternative to invasive methods and expanding potential application in various clinical settings.

Growing Funding Support With a recent seed investment of 1.5 million dollars, Vixiar demonstrates strong investor confidence, supporting further product development and market expansion opportunities within the cardiopulmonary diagnostics sector.

Leadership and Vision The appointment of Kevin Thibodeau as CEO in 2017 and 2019 indicates strategic leadership that can drive commercialization efforts, strengthen market positioning, and forge partnerships with healthcare providers.

Targeted Market Segments Focusing on hospitals, physician offices, and nursing facilities, Vixiar's product aligns with organizations seeking innovative solutions for reducing hospital readmissions and improving patient management in congestive heart failure.

Pipeline for Growth As a spinout from Johns Hopkins University with proprietary technology, Vixiar is well-positioned to expand its product portfolio and capitalize on technological advancements in portable, non-invasive diagnostic devices for cardiopulmonary care.